| Literature DB >> 26147850 |
Richard Sloane1,2,3, Orod Osanlou2,4, David Lewis5, Danushka Bollegala3, Simon Maskell1,3, Munir Pirmohamed2,4.
Abstract
Adverse drug reactions come at a considerable cost on society. Social media are a potentially invaluable reservoir of information for pharmacovigilance, yet their true value remains to be fully understood. In order to realize the benefits social media holds, a number of technical, regulatory and ethical challenges remain to be addressed. We outline these key challenges identifying relevant current research and present possible solutions.Entities:
Keywords: adverse drug reactions; pharmacovigilance; signal generation; social media
Mesh:
Year: 2015 PMID: 26147850 PMCID: PMC4594734 DOI: 10.1111/bcp.12717
Source DB: PubMed Journal: Br J Clin Pharmacol ISSN: 0306-5251 Impact factor: 4.335